Why the study?
Do beta3-adrenoceptor antagonists improve cardiac contractility in patients with chronic heart failure?
Population
Patients with chronic heart failure and other pathophysiological conditions associated with decreased…
Design
Review
Authors
Loading...
Beta3-adrenoceptor antagonists remain investigational in heart failure; leaves open therapeutic potential pending prospective trials.
Do beta3-adrenoceptor antagonists improve cardiac contractility in patients with chronic heart failure?
Beta3-adrenoceptor antagonists represent a potential novel therapeutic target for chronic heart failure by addressing negatively inotropic receptor stimulation.
Moniotte et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: